Retinopathy continues to progress even when diabetic patients try to control their blood sugar, but the molecular mechanism of this 'metabolic memory' phenomenon remains elusive. Retinal mitochondria remain damaged and vicious cycle of free radicals continues to self-propagate. DnA methylation suppresses gene expression, and diabetes activates DnA methylation machinery. our aim was to investigate the role of DnA methylation in continued compromised mitochondrial dynamics and genomic stability in diabetic retinopathy. Using retinal endothelial cells, incubated in 20 mM glucose for four days, followed by 5 mM glucose for four days, and retinal microvessels from streptozotocininduced diabetic rats in poor glycemia for four months, followed by normal glycemia for four additional months, DnA methylation of mitochondrial fusion and mismatch repair proteins, Mfn2 and Mlh1 respectively, was determined. Retinopathy was detected in trypsin-digested microvasculature. Reinstitution of good glycemia had no beneficial effect on hypermethylation of Mfn2 and Mlh1 and retinal function (electroretinogram), and the retinopathy continued to progress. However, intervention of good glycemia directly with DNA methylation inhibitors (Azacytidine or Dnmt1-siRNA), prevented Mfn2 and Mlh1 hypermethylation, and ameliorated retinal dysfunction and diabetic retinopathy. thus, direct regulation of DnA methylation can prevent/reverse diabetic retinopathy by maintaining mitochondrial dynamics and DnA stability, and prevent retinal functional damage. Diabetic retinopathy is the fifth most common cause of preventable blindness, and hyperglycemia and the duration of diabetes are clinically important risk factors for its development and progression. Pivotal Diabetes Control and Complications Trial (DCCT), and the follow-up Epidemiology of Diabetes Interventions and Complications (EDIC), studies have shown that the clinical features of retinopathy continue to develop long after intensive glucose control is maintained in patients treated with the standard treatment regimen during the DCCT. These studies have further demonstrated that intensive control in the early stages of diabetes is critical as its benefits persist beyond the period of its institution, suggesting a 'metabolic memory' phenomenon 1,2. Both in vitro and in vivo experimental models of diabetic retinopathy also have duplicated this memory phenomenon; retinal histopathology initiated during prior poor glycemic control in dogs and rats does not benefit from the good glycemic control which follows it 3,4. However, the molecular mechanism of the metabolic memory phenomenon still remains elusive. Mitochondrial integrity is critical for cell survival, and in diabetes, damaged mitochondria leak cytochrome C, accelerating retinal capillary cell apoptosis, a phenomenon which precedes the formation of acellular capillaries and pericyte ghosts 5-7. Mitochondria are also highly dynamic, and undergo continuous fusion and fission 8,9. Fission helps remove damaged mitochondria, and fusion unites two m...